[1] |
Olsen EA, Abernethy ML, Kulp⁃Shorten C, et al. A double⁃blind, vehicle⁃controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck[J]. J Am Acad Dermatol, 1991,24(5 Pt 1):738⁃743. doi: 10.1016/0190⁃9622(91)70113⁃g.
|
[2] |
Ibbotson S, Stones R, Bowling J, et al. A consensus on the use of daylight photodynamic therapy in the UK[J]. J Dermatolog Treat, 2017,28(4):360⁃367. doi: 10.1080/09546634.2016.1240863.
|
[3] |
Werner RN, Stockfleth E, Connolly SM, et al. Evidence⁃ and consensus⁃based (S3) guidelines for the treatment of actinic keratosis ⁃ International League of Dermatological Societies in cooperation with the European Dermatology Forum ⁃ short version[J]. J Eur Acad Dermatol Venereol, 2015,29(11):2069⁃2079. doi: 10.1111/jdv.13180.
|
[4] |
Nguyen M, Sandhu SS, Sivamani RK. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis ⁃ a review of the literature[J]. Clin Cosmet Investig Dermatol, 2019,12:427⁃435. doi: 10.2147/CCID.S167498.
|
[5] |
Ang JM, Riaz IB, Kamal MU, et al. Photodynamic therapy and pain: a systematic review[J]. Photodiagnosis Photodyn Ther, 2017,19:308⁃344. doi: 10.1016/j.pdpdt.2017.07.002.
|
[6] |
Sotiriou E, Evangelou G, Papadavid E, et al. Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12⁃month follow⁃up results of a randomized, intra⁃individual comparative analysis[J]. J Eur Acad Dermatol Venereol, 2018,32(4):595⁃600. doi: 10.1111/jdv.14613.
|
[7] |
Fargnoli MC, Piccioni A, Neri L, et al. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra⁃patient, prospective, comparison study in Italy[J]. J Eur Acad Dermatol Venereol, 2015,29(10):1926⁃1932. doi: 10.1111/jdv.13076.
|
[8] |
Zhu L, Wang P, Zhang G, et al. Conventional versus daylight photodynamic therapy for actinic keratosis: a randomized and prospective study in China[J]. Photodiagnosis Photodyn Ther, 2018,24:366⁃371. doi: 10.1016/j.pdpdt.2018.10.010.
|
[9] |
Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator⁃blinded, controlled, phase III study throughout Europe[J]. J Eur Acad Dermatol Venereol, 2015,29(12):2342⁃2348. doi: 10.1111/jdv.13228.
|
[10] |
Rubel DM, Spelman L, Murrell DF, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial[J]. Br J Dermatol, 2014,171(5):1164⁃1171. doi: 10.1111/bjd.13138.
|
[11] |
See JA, Gebauer K, Wu JK, et al. High patient satisfaction with daylight⁃activated methyl aminolevulinate cream in the treatment of multiple actinic keratoses: results of an observational study in Australia[J]. Dermatol Ther (Heidelb), 2017,7(4):525⁃533. doi: 10.1007/s13555⁃017⁃0199⁃9.
|
[12] |
Calzavara⁃Pinton P, Zane C, Arisi M, et al. Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area[J]. G Ital Dermatol Venereol, 2018,153(6):764⁃775. doi: 10.23736/S0392⁃0488.18.06071⁃6.
|
[13] |
Philipp⁃Dormston WG, Sanclemente G, Torezan L, et al. Daylight photodynamic therapy with MAL cream for large⁃scale photodamaged skin based on the concept of ′actinic field damage′: recommendations of an international expert group[J]. J Eur Acad Dermatol Venereol, 2016,30(1):8⁃15. doi: 10.1111/jdv.13327.
|
[14] |
See JA, Shumack S, Murrell DF, et al. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia[J]. Australas J Dermatol, 2016,57(3):167⁃174. doi: 10.1111/ajd.12354.
|
[15] |
Morton CA, Wulf HC, Szeimies RM, et al. Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus[J]. J Eur Acad Dermatol Venereol, 2015,29(9):1718⁃1723. doi: 10.1111/jdv.12974.
|
[16] |
Wenande E, Phothong W, Bay C, et al. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side⁃by⁃side, single⁃blind trial in patients with actinic keratosis and large⁃area field cancerization[J]. Br J Dermatol, 2019,180(4):756⁃764. doi: 10.1111/bjd.17096.
|
[17] |
Nissen CV, Heerfordt IM, Wiegell SR, et al. Pretreatment with 5⁃fluorouracil cream enhances the efficacy of daylight⁃mediated photodynamic therapy for actinic keratosis[J]. Acta Derm Venereol, 2017,97(5):617⁃621. doi: 10.2340/00015555⁃2612.
|
[18] |
Galimberti GN. Calcipotriol as pretreatment prior to daylight⁃mediated photodynamic therapy in patients with actinic keratosis: a case series[J]. Photodiagnosis Photodyn Ther, 2018,21:172⁃175. doi: 10.1016/j.pdpdt.2017.11.019.
|
[19] |
Osman⁃Ponchet H, Sevin K, Gaborit A, et al. Lack of effect of selected sunscreens applied on ex vivo human skin for 5⁃methyl⁃aminolevulinic acid penetration and protoporphyrin IX photoactivation[J]. Photodiagnosis Photodyn Ther, 2017,17:75⁃81. doi: 10.1016/j.pdpdt.2016.11.012.
|
[20] |
Ozog DM, Rkein AM, Fabi SG, et al. Photodynamic therapy: a clinical consensus guide[J]. Dermatol Surg, 2016,42(7):804⁃827. doi: 10.1097/DSS.0000000000000800.
|
[21] |
Räsänen JE, Neittaanmäki N, Ylitalo L, et al. 5⁃Aminolaevulinic acid nanoemulsion is more effective than methyl⁃5⁃aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double⁃blind multicentre trial[J]. Br J Dermatol, 2019,181(2):265⁃274. doi: 10.1111/bjd.17311.
|
[22] |
Neittaanmäki⁃Perttu N, Karppinen TT, Tani T, et al. Long⁃term outcome of low⁃concentration hexyl⁃5⁃aminolaevulinate daylight photodynamic therapy for treatment of actinic keratoses[J]. Acta Derm Venereol, 2017,97(1):120⁃121. doi: 10.2340/00015555⁃2484.
|
[23] |
Vignion⁃Dewalle AS, Baert G, Thecua E, et al. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: how relevant are effective light dose and local damage in predicting the complete response rate at 3 months?[J]. Lasers Surg Med, 2018,50(5):576⁃589. doi: 10.1002/lsm.22827.
|
[24] |
Wiegell SR, Haedersdal M, Philipsen PA, et al. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single⁃blinded study[J]. Br J Dermatol, 2008,158(4):740⁃746. doi: 10.1111/j.1365⁃2133.2008.08450.x.
|
[25] |
Wiegell SR, Fabricius S, Stender IM, et al. A randomized, multicentre study of directed daylight exposure times of 1[12] vs. 2[12] h in daylight⁃mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp[J]. Br J Dermatol, 2011,164(5):1083⁃1090. doi: 10.1111/j.1365⁃2133.2011.10209.x.
|
[26] |
Wiegell SR, Fabricius S, Heydenreich J, et al. Weather conditions and daylight⁃mediated photodynamic therapy: protoporphyrin IX⁃weighted daylight doses measured in six geographical locations[J]. Br J Dermatol, 2013,168(1):186⁃191. doi: 10.1111/j.1365⁃2133.2012.11200.x.
|
[27] |
O′Mahoney P, Khazova M, Eadie E, et al. Measuring daylight: a review of dosimetry in daylight photodynamic therapy[J]. Pharmaceuticals (Basel), 2019,12(4):143. doi: 10.3390/ph1204 0143.
|
[28] |
O′Gorman SM, Clowry J, Manley M, et al. Artificial white light vs daylight photodynamic therapy for actinic keratoses: a randomized clinical trial[J]. JAMA Dermatol, 2016,152(6):638⁃644. doi: 10.1001/jamadermatol.2015.5436.
|
[29] |
Gutiérrez García⁃Rodrigo C, Pellegrini C, Piccioni A, et al. Single versus two⁃treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: an intra⁃patient randomized trial[J]. Photodiagnosis Photodyn Ther, 2019,27:100⁃104. doi: 10.1016/j.pdpdt.2019.05. 031.
|
[30] |
Gracia⁃Cazaña T, Malinis A, Almagro⁃Sánchez M, et al. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: an observational, prospective, comparative study[J]. Photodiagnosis Photodyn Ther, 2019,27:34⁃38. doi: 10.1016/j.pdpdt.2019.05.030.
|
[31] |
Karrer S, Aschoff R, Dominicus R, et al. Methyl aminolevulinate daylight photodynamic therapy applied at home for non⁃hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany[J]. J Eur Acad Dermatol Venereol, 2019,33(4):661⁃666. doi: 10.1111/jdv.15422.
|